|
Index of reports
> Cases resulting in disability (31)
> Cases with Dyspnoea (7)
Below is the selection of adverse event reports related to Norvasc (Amlodipine) that includes cases resulting in disability where reactions include dyspnoea.
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Novonorm
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a pharmacist from Germany on 2007-10-11
Patient: male, weighing 90.0 kg (198.0 pounds)
Adverse reactions / side effects: Dyspnoea, Coma, Intracranial Aneurysm, Cerebral Haemorrhage
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Ramipril
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Brazil on 2007-05-08
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a individual with unspecified qualification on 2007-05-04
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Ineffective, Impaired Work Ability, Fatigue, Malaise, Palpitations, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction
Adverse event resulted in: disablity
Suspect drug(s):
Olmetec (Olmesartan Medoxomil) (20 Milligram, Tablet) (Olmesartan Medo
Dosage: 20 mg (20 mg, qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet (Tablet)
Dosage: 20/10 mg (mg, bid), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Olmesartan Medoxomil
Dosage: 20 mg (20 mg, qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet
Dosage: 20/10 mg (mg, bid), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Norvasc
Other drugs received by patient: Diabinese (Chlorpropamide) (Chlorpropamide); Norvasc; Insulin (Insulin) (Insulin); Diabinese; Insulin
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Brazil on 2007-05-01
Patient: female
Adverse reactions / side effects: Dyspnoea, Drug Ineffective, Syncope, Fatigue, Malaise, Palpitations, Arterial Occlusive Disease, Oedema, Pulmonary Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Olmetec
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Aldactone
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Insulin
Indication: Diabetes Mellitus
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Brazil on 2007-04-02
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Olmetec
Dosage: daily dose:20mg
Administration route: Oral
Caduet
Administration route: Oral
Aldactone
Dosage: text:5/10 mg (milligram)
Administration route: Oral
Coristina D
Administration route: Oral
Insulin
Indication: Diabetes Mellitus
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Brazil on 2007-03-20
Patient: female
Adverse reactions / side effects: Dyspnoea, Malaise, Pulmonary Oedema, Arterial Occlusive Disease, Oedema, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Administration route: Oral
Olmetec
Administration route: Oral
Caduet
Administration route: Oral
Aldactone
Administration route: Oral
Coristina D
Administration route: Oral
Insulin
|
